Soluble Urokinase-Type Plasminogen Activator Receptor as a Biomarker of Treatment Response in Childhood Tuberculosis

被引:2
作者
Olivianto, Ery [1 ]
Sudarwati, Sri [2 ]
Nataprawira, Heda Melinda [2 ]
机构
[1] Univ Brawijaya, Saiful Anwar Gen Hosp, Fac Med, Dept Child Hlth,Div Pediat Respirol, Malang, Indonesia
[2] Univ Padjadjaran, Hasan Sadikin Gen Hosp, Fac Med, Dept Child Hlth,Div Pediat Respirol, Bandung, Indonesia
关键词
Childhood tuberculosis; soluble urokinase-type plasminogen activator receptor serum level; treatment response; SYSTEM; SUPAR;
D O I
10.4103/ijmy.ijmy_52_19
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Childhood tuberculosis (TB) is a major health problem worldwide, especially in developing countries. In 2015, there are estimated 950,000 cases of childhood TB. Since most TB in children is paucibacillary, this gives rise not only to problem in diagnosing but also in monitoring the response to anti-TB treatment as well. Soluble urokinase-type plasminogen activator receptor (suPAR), a glycosylphosphatidylinositol-linked membrane protein of various cells of immune system, is one of the potential biomarkers to be used in the management of TB. The objective of this study is to study the decrease of scrum suPAR level after anti-TB treatment in children with TB and its association with patient characteristics. Methods: We conducted a prospective study on children suspected of having TB due to a history of contact with active TB case and symptoms such as coughing, fever, and enlarged lymph nodes. The diagnosis of TB is established by history, physical examination including anthropometric examination. Tuberculin skin test using PPD RT-23 and interferon-gamma releasing assay with Quantiferon TB-Gold Plus was performed. Chest X-rays were read by two independent radiologists. Microbiological examination was perfonned using microscopic examination and Xpert MTB/RIF. The level of suPAR before and after anti-TB treatment was examined with the Elisa method. Results: There was no significant difference of serum suPAR levels before and after anti-TB treatment (mean 0.71 [standard deviation 0.585] ng/mL; P = 0.072). There was no association between ages (P = 0.112), nutritional status (P = 0.228), diagnosis of pulmonary or extrapulmonary TB (P = 0.956), and radiological feature (P = 0.810) with serum suPAR levels decrease. Conclusion: There is no suPAR serum level decrease 2 months after treatment with anti-TB and there is no association with age, nutritional status, pulmonary or extrapulmonary TB diagnosis, and radiological feature.
引用
收藏
页码:262 / 266
页数:5
相关论文
共 30 条
  • [1] [Anonymous], 2015, RECEPTORS CLIN INVES
  • [2] [Anonymous], 2013, Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update
  • [3] Caulfield Adam J, 2016, J Clin Tuberc Other Mycobact Dis, V4, P33, DOI 10.1016/j.jctube.2016.05.005
  • [4] Del Rosso M, 2011, CURR PHARM DESIGN, V17, P1924
  • [5] Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan Kementerian Kesehatan Republik Indonesia, 2016, PET TEKN MAN TB AN
  • [6] Soluble Urokinase Plasminogen Activator Receptor: A New Biomarker in the Pediatric Intensive Care Unit
    El-Mekkawy, Muhammad S.
    Saleh, Nagwan Y.
    Sonbol, Ahmed A.
    [J]. INDIAN JOURNAL OF PEDIATRICS, 2016, 83 (07) : 661 - 669
  • [7] The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia
    Erkut, Nergiz
    Mentese, Ahmet
    Ozbas, Hasan Mucahit
    Ermantas, Nilay
    Sumer, Aysegul
    Orem, Asim
    Sonmez, Mehmet
    [J]. TURKISH JOURNAL OF HEMATOLOGY, 2016, 33 (02) : 135 - 140
  • [8] Soluble urokinase-type plasminogen activator receptor (suPAR) - a possible biomarker for bacteremia in sepsis
    Georgescu, Anca-Meda
    Szederjesi, Janos
    Voidazan, Septimiu
    Dobreanu, Minodora
    Copotoiu, Sanda Maria
    Hutanu, Adina
    Azamfirei, Leonard
    [J]. REVISTA ROMANA DE MEDICINA DE LABORATOR, 2015, 23 (01): : 59 - 73
  • [9] Childhood TB: When to think of it and what to do when you do
    Hertting, Olof
    Shingadia, Delane
    [J]. JOURNAL OF INFECTION, 2014, 68 : S151 - S154
  • [10] Indumati V, 2017, Indian J Tuberc, V64, P206, DOI 10.1016/j.ijtb.2017.01.012